A 12-week open-label extension study to assess the efficacy and safety of combination of tolterodine and pilocarpine in the treatment of patients with overactive bladder after 12-week randomized controlled study

Research Type

Clinical

Abstract Category

Overactive Bladder

Watch this session

Links
	Abstract 525
	Female Lower Urinary Tract Symptoms 2 Scientific Podium Short Oral Session 30
	Friday 15th September 2017
	09:52 - 10:00
	Spadolini D
	Overactive Bladder Pharmacology Prospective Study Quality of Life (QoL)
	1. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 2. Department of Urology, Pusan National University Hospital, 3. Department of Urology, Seoul National University Hospital, 4. Department of Urology, Konkuk University Medical Center, Konkuk University School of Medicine, 5. Department of Urology, Inje University Busan Paik Hospital, Inje University College of Medicine, 6. Department of Urology, CHA Bundang Medical Center, CHA University, 7. Department of Urology, Kwangju Christian Hospital, Gwangju, Korea
Presenter
K Kyu-Sung Lee
Abstract PDF Edit Abstract Abstract Centre